References
- Boisclair Y. R., Brown A. L., Casola S., Rechler M. M. Three clustered Spl sites are required for efficient transcription of the TATA-less promoter of the gene for insulin-like growth factor-binding protein-2 from the rat. J. Biol. Chem. 1993; 268: 24892–24901
- Brown A., Rechler M. M. Cloning of the rat insulinlike growth factor binding protein-2 gene and identification of a functional promoter lacking a TATA box. Mol. Endocrinol. 1990; 4: 2039–2051
- Cazals V., Mouhieddine B., Maittre B., Le Bouc Y., Chadclat K., Brondy J., Clement A. Insulin-like growth factor, their binding proteins, and transforming growth factor-b1 in oxidant-arrested lung alveolar epithelial cells. J. Biol. Chem. 1994; 269: 14111–14117
- Elmlinger M. W., Wimmer K., Biemer E., Dannecker L., Blum W. F., Ranke M. B., Dannecker G. E. Insulinlike growth factor binding protein 2 is differentially expressed in leukemic B-and T-cell lines. Growth Reg. 1996; 6: 152–157
- Gregory P. D., Horz W. Chromatin and transcription. Eur. J. Biochem. 1998; 251: 9–18
- Kutoh E., Margot J., Schwander J. Genomic structure and regulation of the promoter of the rat insulin-like growth factor binding protein-2 gene. Mol. Endocrinol. 1993; 7: 1295–1316
- Kutoh E., Schwander J., Margot J. Cell density-dependent modulation of the rat insulin-like growth factor binding protein-2 and its gene. Eur. J. Biochem. 1995; 234: 557–562
- Lin R. J., Nagy L., Inoue S., Shao W., Miller W. H., Jr., Evans R. M. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 1998; 391(6669)811–814
- Luckow B., Schütz G. CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res. 1987; 15: 5490
- Mottola C., MacDonald R., Brackett J., Mole J., Anderson J., Czech M. Purification and amino-terminal sequence of an insulin-like growth factor binding protein secreted by rat liver BRL-3A cells. J. Biol. Chem. 1986; 261: 11180–11188
- Mouhieddine O. B., Cazals V., Kuto E., Le Bouc Y., Clement A. Glucocorticoid-induced growth arrest of lung alveolar epithelial cells is associated with increased production of insulin-like growth factor binding protein-2. Endocrinolgy 1996; 137: 287–295
- Oh Y. IGF-independent regulation of breast cancer growth by IGF binding proteins. Breast Cancer Res. Treat. 1998; 47(3)283–293
- Reeve J. G., Morgan J., Schwander J., Bleehen N. M. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors. Cancer Res. 1993; 53: 4680–4685
- Sambrook J., Fritsch E., Maniatis T. Molecular Cloning: A Laboratory Manual, 2nd Edition. 1989
- Schwander J., Mary J.-L. The RIA for IGFBP-2 in man a meagre catch?. Growth 1993; 3: 104–108
- Schwander J., Kutoh E., Mary J.-L., Ritz L. The Gene Regulation of Insulin-like Growth Factor Binding Protein-2 (IGFBP-2), Baxter, et al. Elsevier Science B.V. 1994
- Selden R. F., Howie K. B., Rowe M. E., Goodman H. M., More D. D. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 1986; 6: 3173–3179
- Smale S., Baltimore D. The initiator as a transcription control element. Cell 1989; 57: 103–113
- Sterling K., Weaver J., Ho K., Xu L., Bresnick E. Rat CYP1A1 negative regulatory element: biological activity and interaction with a protein from liver and hepatoma cells. Mol. Pharmacol. 1993; 44: 560–568
- Umesono K., Giguere V., Glass C., Rosenfeld M., Evans R. Nature 1988; 336: 262–265